David Badawi - 26 Dec 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Chief Technology Officer, Director
Signature: /s/Jeremy Hayden, Attorney-in-Fact for David Badawi
Issuer symbol: SGHT
Transactions as of: 26 Dec 2025
Net transactions value: +$4,892
Form type: 4
Filing time: 30 Dec 2025, 16:11:38 UTC
Previous filing: 03 Oct 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Badawi David	Chief Technology Officer, Director	C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK	/s/Jeremy Hayden, Attorney-in-Fact for David Badawi	30 Dec 2025	0001870825

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Options Exercise	$4,892	+21,270	+1.1%	$0.2300	1,926,769	26 Dec 2025	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGHT	Stock Option (Right to Buy)	Options Exercise	$0	-21,270	-50%	$0.000000	21,270	26 Dec 2025	Common Stock	21,270	$0.2300	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan.
F2	Includes (i) 1,758,996 shares of common stock, and (ii) 167,773 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested.
F3	The Reporting Person previously reported a grant of 28,100 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 39,100 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 43,375 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares.
F4	The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020.